Asian Growth Stocks With Strong Insider Ownership
As the Asian markets navigate a complex economic landscape marked by trade tensions and stimulus expectations, investors are increasingly looking towards growth companies with strong insider ownership as potential opportunities. In this context, stocks that exhibit robust internal confidence through significant insider holdings can be particularly appealing, suggesting alignment between management and shareholder interests amidst evolving market conditions.
Name
Insider Ownership
Earnings Growth
Zhejiang Leapmotor Technology (SEHK:9863)
15.6%
59.9%
Vuno (KOSDAQ:A338220)
15.6%
109.8%
Shanghai Huace Navigation Technology (SZSE:300627)
24.3%
23.5%
Schooinc (TSE:264A)
30.6%
68.9%
Oscotec (KOSDAQ:A039200)
21.1%
94.4%
NEXTIN (KOSDAQ:A348210)
12.4%
33.8%
Nanya New Material TechnologyLtd (SHSE:688519)
11%
63.3%
M31 Technology (TPEX:6643)
30.8%
63.4%
Laopu Gold (SEHK:6181)
35.5%
40.2%
Fulin Precision (SZSE:300432)
13.6%
43%
Click here to see the full list of 613 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★★★
Overview: CLASSYS Inc. is a global provider of medical aesthetics devices with a market cap of ₩4.02 billion.
Operations: The company generates revenue of ₩269.67 billion from its Surgical & Medical Equipment segment.
Insider Ownership: 13.6%
CLASSYS demonstrates strong growth potential with earnings expected to grow 26.6% annually, outpacing the Korean market's average. Recent Q1 results showed a revenue increase to ₩77.1 billion and net income of ₩29.7 billion, indicating solid performance. The company's shares trade at 28% below estimated fair value, suggesting potential undervaluation. Despite no significant insider trading activity in recent months, CLASSYS maintains high insider ownership, aligning management interests with shareholders'.
Click here to discover the nuances of CLASSYS with our detailed analytical future growth report.
Our valuation report unveils the possibility CLASSYS' shares may be trading at a premium.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Chenbro Micom Co., Ltd. is involved in the R&D, design, manufacture, processing, and trading of computer peripherals and expendable systems across various international markets including the United States, China, Taiwan, and Singapore with a market cap of NT$46.28 billion.
Operations: The company's revenue primarily comes from its computer peripherals segment, which generated NT$15.90 billion.
Insider Ownership: 24.9%
Chenbro Micom demonstrates promising growth potential with revenue forecasted to grow 22.1% annually, surpassing the Taiwanese market average. Recent Q1 results showed significant earnings growth of 57.1% year-on-year, reflecting robust performance. The company's strategic focus on AI and cloud server solutions at COMPUTEX 2025 underscores its commitment to innovation and market expansion. High insider ownership aligns management's interests with shareholders', although recent months show no notable insider trading activity.
Delve into the full analysis future growth report here for a deeper understanding of Chenbro Micom.
Upon reviewing our latest valuation report, Chenbro Micom's share price might be too optimistic.
Simply Wall St Growth Rating: ★★★★★★
Overview: Kaori Heat Treatment Co., Ltd. specializes in the research, development, manufacture, and sale of heat exchanger solutions across Taiwan, Asia, the United States, Europe, and other international markets with a market cap of approximately NT$26.80 billion.
Operations: Kaori Heat Treatment Co., Ltd.'s revenue is primarily derived from its Plate Heat Exchanger segment, generating NT$1.59 billion, and its Energy Conservation Product Segment, which includes Metal Products and Processing, contributing NT$2.63 billion.
Insider Ownership: 13%
Kaori Heat Treatment, with substantial insider ownership, is positioned for significant growth, as its earnings are expected to increase by 30.6% annually over the next three years, outpacing the Taiwanese market. The company reported strong Q1 sales of TWD 1.01 billion and announced a share buyback program worth TWD 859.05 million to enhance shareholder value. Despite recent share price volatility, Kaori's strategic initiatives and amendments to its corporate charter reflect a proactive approach to sustaining growth momentum.
Get an in-depth perspective on Kaori Heat Treatment's performance by reading our analyst estimates report here.
Insights from our recent valuation report point to the potential overvaluation of Kaori Heat Treatment shares in the market.
Access the full spectrum of 613 Fast Growing Asian Companies With High Insider Ownership by clicking on this link.
Interested In Other Possibilities? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include KOSDAQ:A214150 TWSE:8210 and TWSE:8996.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
A South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin Treasury
Bridge Biotherapeutics (288330), a South Korean biotech company, may be looking to become the country's answer to Strategy (MSTR) or Metaplanet (3350) by adopting a bitcoin treasury strategy. Seongnam-based Bridge has received a 25 billion won ($183.3 million) backing from crypto investment firm Parataxis, with which it will build a BTC treasury. Bridge will change its corporate name to Parataxis Korea and continue to trade on the South Korean stock market KOSDAQ, according to an announcement on Friday. "Inspired by the growing interest in BTC treasury strategies seen in companies like Strategy in the U.S. and Metaplanet in Japan, we believe institutional interest in this space is increasing globally," Parataxis partner Andrew Kim said. More and more companies are copying the playbook of Strategy, which owns more than 2.8% of all the bitcoin that will ever exist. Tokyo-listed hotel operator turned bitcoin investor Metaplanet holds 10,000 BTC ($1.04 billion), making it the largest holding of a public company outside North America. These firms have witnessed dramatic appreciation in their share price as traders cash in on them as a bitcoin-proxy asset. Bridge joins fellow healthcare-adjacent companies Semler Scientific (SMLR) and Prenetics Global (PRE) in adopting a bitcoin treasury strategy. Parataxis is currently preparing to go public in the U.S. via a special purpose acquisition company (SPAC), SilverBox Corp IV (SBXD). Bridge shares closed over 20.5% higher on Friday at 943 won ($0.69).
Yahoo
5 hours ago
- Yahoo
Gold Slips Despite Rising Global Tensions
Happy Friday, traders. Welcome to our weekly market wrap, where we take a look back at these last five trading days with a focus on the market news, economic data, and headlines that had the most impact on gold prices and other key correlated assets— and may continue to in the future. Gold prices have slipped throughout the last five trading days, positioning the yellow metal for its first weekly loss in nearly a month. Gold posted its first weekly loss in nearly a month, despite rising geopolitical risks. The Fed held rates steady but signaled two cuts are still expected this year. Retail Sales data came in soft, and equities struggled across the board. A stronger US Dollar may be capping gold's rally amid global uncertainty. Since tracking back below $3400/oz shortly after the Sunday night opens, gold's trading path this week has been steadily, but not rapidly, down and to the right. A loss week-over-week in gold spot prices (the first in three) is not what we would have expected given the geopolitical developments of recent days, but it's very much the story of this week, so let's talk about it. Without wanting to be at all sensationalist, it is possible that the world is slipping towards another, much larger and much more volatile escalation of war in the Middle East with the direct participation of the United States. There are few other events—if when they're only 'possible'—that should have a more direct risk-off impact on global markets, pushing investors into the prime safe havens like gold. And yet, the yellow metal has steadily fallen back this week. Eventually, gold discovered support in the neighborhood of $3370, although Friday's Asian sessions did see the metal dip briefly as low as $3345. On Wednesday, the FOMC announced (as expected) no changes to monetary policy following their June meeting but reiterated that the committee still expects to make two cuts this year. This probably nets out as neutral for gold (lower rates not yet, but still planned), but if you had to tip the hand one way or the other, you might expect prices to step slightly higher. At the same time, the quarterly update to the Fed's economic projections indicates the central bankers now expect weaker growth in the US economy in the near-to-medium term. This, too, should be a basic risk-off signal and would be reasonable to expect as a tailwind for gold. There have been other, softer data points this week that we would have projected to make traders more risk-averse, to the benefit of the gold prices. Monday's Retail Sales data came in below already-muted expectations, and all three major US stock indexes have struggled this week, primarily under the clouds of war. Still, gold spot is all but certain to close out this week in the red. There are two possible reasons for this at the top of our minds currently. To be sure, the US Dollar has enjoyed greater safe-haven interest from traders and investors this week, and aside from that dynamic, just the fact of an appreciating Dollar typically pushes down on gold. But what may also be a factor here, after nearly two full quarters of record-breaking gains, is that the 2025 gold rally has fully extended itself, and even the threat of the globe's only remaining 20th Century superpower entering a war isn't adding enough gas to the conflagration to move spot prices towards $3500. For now, the absent upward momentum is not being translated to downward pressure, but if gold doesn't find new legs soon, we may see a more aggressive pace of liquidations as investors sell off richer positions in gold to balance out losses on equities and elsewhere if the global state of play remains on high alert or deteriorates further. In the meantime, traders, I hope you can get out and safely enjoy your weekend for the next couple of days. After that, I'll see you back here next week for another market recap.
Yahoo
9 hours ago
- Yahoo
Why AI Stock Astera Labs Was Crushing It This Week
The company has found an appropriate partner to help it win more AI-related business. It's teaming up with a specialty chipmaker based in Asia. 10 stocks we like better than Astera Labs › According to data compiled by S&P Global Market Intelligence, Astera Labs (NASDAQ: ALAB) stock's price was floating almost 11% higher week to date on early Friday morning. Investors were mainly reacting to news the tech infrastructure company reported about a new business tie-up with an Asian peer. On Monday, Astera and Taiwanese chipmaker AIChip Technologies announced in a joint press release that they have formed a strategic business partnership. Together, the two will aim to exploit opportunities afforded by sky-high demand for artificial intelligence (AI) functionalities. AIChip, which specializes in application-specific integrated circuit (ASIC) chips, and Astera are teaming up to offer "validated, interoperable solutions for hyperscalers building next-generation AI infrastructure," according to the press release. As the name suggests, a hyperscaler is essentially an extremely large data center. These are in vogue now due to the heavy resource requirements of AI. Astera and AIChip offered almost no details about their new partnership, including its financial parameters. Given that, it's tough to gauge how this collaboration might affect their fundamentals. Judging by the market's reaction, though, investors don't seem to mind -- teaming up on projects has clear potential to benefit both companies. I think AI companies like Astera are in the midst of a gold rush. I'd absolutely consider buying the stock. Before you buy stock in Astera Labs, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Astera Labs wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why AI Stock Astera Labs Was Crushing It This Week was originally published by The Motley Fool Sign in to access your portfolio